Correlation Between Qualigen Therapeutics and Data Knights
Can any of the company-specific risk be diversified away by investing in both Qualigen Therapeutics and Data Knights at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qualigen Therapeutics and Data Knights into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Qualigen Therapeutics and Data Knights Acquisition, you can compare the effects of market volatilities on Qualigen Therapeutics and Data Knights and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qualigen Therapeutics with a short position of Data Knights. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qualigen Therapeutics and Data Knights.
Diversification Opportunities for Qualigen Therapeutics and Data Knights
-0.64 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Qualigen and Data is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Qualigen Therapeutics and Data Knights Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Data Knights Acquisition and Qualigen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qualigen Therapeutics are associated (or correlated) with Data Knights. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Data Knights Acquisition has no effect on the direction of Qualigen Therapeutics i.e., Qualigen Therapeutics and Data Knights go up and down completely randomly.
Pair Corralation between Qualigen Therapeutics and Data Knights
Given the investment horizon of 90 days Qualigen Therapeutics is expected to under-perform the Data Knights. In addition to that, Qualigen Therapeutics is 28.5 times more volatile than Data Knights Acquisition. It trades about -0.04 of its total potential returns per unit of risk. Data Knights Acquisition is currently generating about 0.14 per unit of volatility. If you would invest 1,044 in Data Knights Acquisition on August 26, 2024 and sell it today you would earn a total of 61.00 from holding Data Knights Acquisition or generate 5.84% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 31.99% |
| Values | Daily Returns |
Qualigen Therapeutics vs. Data Knights Acquisition
Performance |
| Timeline |
| Qualigen Therapeutics |
| Data Knights Acquisition |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Qualigen Therapeutics and Data Knights Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Qualigen Therapeutics and Data Knights
The main advantage of trading using opposite Qualigen Therapeutics and Data Knights positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qualigen Therapeutics position performs unexpectedly, Data Knights can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Data Knights will offset losses from the drop in Data Knights' long position.| Qualigen Therapeutics vs. ZyVersa Therapeutics | Qualigen Therapeutics vs. Immix Biopharma | Qualigen Therapeutics vs. Phio Pharmaceuticals Corp | Qualigen Therapeutics vs. 180 Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |